In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares closed yesterday at $91.05.
According to TipRanks, S Macdonald is a 5-star analyst with an average return of 12.5% and a 64.72% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Humana, Option Care Health, and Cigna.
The word on The Street in general, suggests a Hold analyst consensus rating for Amedisys with a $100.67 average price target.
AMED market cap is currently $2.98B and has a P/E ratio of -291.43.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Amedisys (AMED) Company Description:
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
